Antiretroviral therapy during tuberculosis treatment and marked reduction in death rate of HIV-infected patients, Thailand. - Wikidata - wikimedia - TriplyDB

Antiretroviral therapy during tuberculosis treatment and marked reduction in death rate of HIV-infected patients, Thailand.

Antiretroviral therapy during tuberculosis treatment and marked reduction in death rate of HIV-infected patients, Thailand.

http://www.wikidata.org/entity/Q33884068

about

Social stigma and knowledge of tuberculosis and HIV among patients with both diseases in Thailand Current trends and intricacies in the management of HIV-associated pulmonary tuberculosis Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis Treatment outcomes of patients co-infected with tuberculosis and HIV at Chiang Mai University Hospital, Thailand Cost and cost-effectiveness of tuberculosis treatment shortening: a model-based analysis.Childhood TB epidemiology and treatment outcomes in Thailand: a TB active surveillance network, 2004 to 2006 Directly observed therapy and improved tuberculosis treatment outcomes in Thailand.HIV care and treatment factors associated with improved survival during TB treatment in Thailand: an observational study Linking HIV-infected TB patients to cotrimoxazole prophylaxis and antiretroviral treatment in India.HIV-specific health care utilization and mortality among tuberculosis/HIV coinfected persons.Patients diagnosed with tuberculosis at death or who died during therapy: association with the human immunodeficiency virus The impact of HAART initiation timing on HIV-TB co-infected patients, a retrospective cohort study Improved early results for patients with extensively drug-resistant tuberculosis and HIV in South Africa.Early versus delayed fixed dose combination abacavir/lamivudine/zidovudine in patients with HIV and tuberculosis in Tanzania.Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIV negative patients: a systematic review Effectiveness of early antiretroviral therapy initiation to improve survival among HIV-infected adults with tuberculosis: a retrospective cohort study Antiretroviral therapy for control of the HIV-associated tuberculosis epidemic in resource-limited settings.Evaluation of the rapid scale-up of collaborative TB/HIV activities in TB facilities in Rwanda, 2005-2009.Factors impacting early mortality in tuberculosis/HIV patients: differences between subjects naïve to and previously started on HAART.The impact of antiretroviral therapy on mortality in HIV positive people during tuberculosis treatment: a systematic review and meta-analysis.Epidemiology of HIV-associated tuberculosis.Predictors of mortality among TB-HIV Co-infected patients being treated for tuberculosis in Northwest Ethiopia: a retrospective cohort study.Timing, rates, and causes of death in a large South African tuberculosis programme.The effect of HIV and antiretroviral therapy on characteristics of pulmonary tuberculosis in northern Malawi: a cross-sectional study Lives saved by tuberculosis control and prospects for achieving the 2015 global target for reducing tuberculosis mortality Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2014, Thailand.The complex relationship between human immunodeficiency virus infection and death in adults being treated for tuberculosis in Cape Town, South Africa Antiretroviral therapy uptake among adult tuberculosis patients newly diagnosed with HIV in Nyanza Province, Kenya The impact of HIV status and antiretroviral treatment on TB treatment outcomes of new tuberculosis patients attending co-located TB and ART services in South Africa: a retrospective cohort study.The Impact and Cost-Effectiveness of a Four-Month Regimen for First-Line Treatment of Active Tuberculosis in South Africa.Vitamin D status in HIV-infected patients with and without tuberculosis: a pilot study.Causes of mortality among tuberculosis and HIV co-infected patients in Chiang Rai, Northern Thailand.Antiretroviral treatment as prevention: impact of the 'test and treat' strategy on the tuberculosis epidemic.Infectious disease mortality rates, Thailand, 1958-2009.New drugs and regimens for treatment of TB.Causes of death in HIV-infected persons who have tuberculosis, Thailand.Antiretroviral therapy and TB notification rates in a high HIV prevalence South African community.Management of individuals requiring antiretroviral therapy and TB treatment.Tuberculosis and HIV co-infection: screening and treatment strategies.Trends and barriers to HIV testing among tuberculosis patients in Prey Kabas operational district, Takeo province, Cambodia.

P2860

Q21562382-04F48431-4A7A-4C67-9591-F79F86EBF983 Q28069032-2A892350-1F45-40E1-BEEE-8BC513E2C847 Q28477855-C855B99B-5443-444E-9A31-8F6242C35BB2 Q30051056-F7922ABC-B607-4933-B57D-7E6565A012F2 Q30830344-224E7D2F-B233-4115-A649-B353D9D20ED8 Q33352861-988DCF0E-C0C8-407B-B576-6617233DD2BD Q33366419-BF001C20-4366-4F26-BBAD-400AB0077069 Q33429719-1233AE2C-6B3B-45BC-AB2B-305D903B21DC Q33471454-6275A071-FE50-4FD1-A38E-A05F5DC84934 Q33705696-CD02E787-3870-45D0-BFA5-7FA40B852AF9 Q33746063-792CAD85-D1D6-4B7F-96E5-372FB5D385F6 Q33758612-133CC1F3-0DCD-4676-8B2E-B67FAAC58AB2 Q33794794-092FC416-1A92-4544-946F-118DF457AEB8 Q33807615-DD3389A1-3F04-45A3-83C7-ADC68F65808D Q33869390-A8A7ACA4-F311-461B-8178-58B09F4D8DBE Q33894801-FFDF0C06-FA0C-4B88-86B8-33790A02D5B4 Q33920318-2E6E48E9-87C6-4AAF-B21F-387701417FE5 Q33957232-FF1BBB49-349C-4E31-AD47-49418A6134A9 Q34438327-445EAE6B-148C-4B72-AA5C-49AFAED82713 Q34497528-DCCBDCC7-721C-4827-BCBC-A5E73462C553 Q34519940-04369D0B-C9C4-48A9-B537-47861C45DACF Q34787863-ED83531A-D279-47B5-AE27-53493E6FB2A9 Q34979324-14E6BD79-3A9C-4D75-B494-86BA15ACC9CF Q35102704-C359DB3A-2744-403F-8D9E-A3438614D6FC Q35149050-78B63B6C-A32E-4B10-B298-2CEAFEA3464F Q35530299-CE401E14-D90B-4009-A63D-6D1DB7EF4F7E Q35665530-9B95E340-3320-484F-9F8C-436EE48051D3 Q35719624-3FA5FD00-F602-44E1-9926-5A65B292C65E Q35846261-967D69E0-18B8-494B-BE62-2B129D697AC4 Q35881727-8A4D209B-DE2C-4755-B916-76C0FA4D8A7F Q36293387-1E6096A8-AE1D-4D20-BA0A-E7822CCC9A11 Q36311260-1C049B6E-84C9-49C0-93CD-BD8FC3E322F1 Q36509003-EF319840-9A99-445D-ABF9-707D633035DA Q36574316-2527B0BD-0953-4547-99E8-1C4860DC59FB Q36825354-E3F641C5-552E-462B-8909-3884A6693CC1 Q37133305-41BB1095-781F-4799-9FF4-979C09C08797 Q37240770-B517501D-468D-4417-9585-3CB0F636F887 Q37666456-9C04D7B5-BCDF-47EA-ADCF-827BF9CE6A25 Q37895251-A4A7F76F-F997-4D07-BA7A-3FCFAB5FEFB3 Q47752459-876463FF-79DB-48D6-87B6-70F5FFD59D1E

P2860

Antiretroviral therapy during tuberculosis treatment and marked reduction in death rate of HIV-infected patients, Thailand.

http://www.wikidata.org/entity/Q33884068

description

2007 nî lūn-bûn

@nan

2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Antiretroviral therapy during ...... V-infected patients, Thailand.

@ast

Antiretroviral therapy during ...... V-infected patients, Thailand.

@en

type

label

Antiretroviral therapy during ...... V-infected patients, Thailand.

@ast

Antiretroviral therapy during ...... V-infected patients, Thailand.

@en

prefLabel

Antiretroviral therapy during ...... V-infected patients, Thailand.

@ast

Antiretroviral therapy during ...... V-infected patients, Thailand.

@en

P1433

Q33884068-DEA0C0B6-4FCA-4C04-AEAD-EBD4A0CBE57E

P1476

Q33884068-61327F52-67EA-4810-9652-56EBDBA32667

P2093

Q33884068-0667910A-E023-4EA5-B3ED-2B0D7720C196

Q33884068-7E570951-F9E6-4557-98D7-1BEDAF3B27FB

Q33884068-96BD9E9E-5B0F-48E2-82BA-E094C1706304

Q33884068-AD19EAAF-E6D6-4BA7-BCE4-78F8D429BD86

Q33884068-C9D0897B-E38B-44A1-908B-2DFCA2E1F901

Q33884068-D146D290-EB6D-41FE-B1D0-6777D1BD710D

Q33884068-DCAA45BF-EAF7-421A-ADC7-1E40B4446285

Q33884068-E379A72F-4857-431B-80AC-917FAA4CEB07

Q33884068-FB3A01E7-2A7A-468F-BDF1-3B1831F105CB

Q33884068-FCDDA946-993B-4E97-BAB1-7B0F3833F599

P2860

Q33884068-13A1910B-5A69-451F-8289-8A1A07A68BA7

Q33884068-14CC1C70-6E28-410F-8503-584042B844BB

Q33884068-1ECB4099-36DC-4749-A30D-37D407991EBC

Q33884068-20832F65-E308-4C8E-9721-D9D3AD2A5117

Q33884068-2C7090C5-964D-4FFD-B013-56EB4B05BF21

Q33884068-2CC8668D-FED5-4F07-B5AE-54150EE2988F

Q33884068-3000C66B-027D-4AC2-8AD3-9EC54CEDE2FC

Q33884068-3FC5E5DC-BF14-4C12-A08E-EA921982545E

Q33884068-420B1C63-7B70-4827-9A95-9297A0D3221B

Q33884068-52AB0BDF-1363-4636-9837-8FC5470C8B14

P304

Q33884068-99D5E911-0A8D-4914-94A7-BB51B4157BDC

P31

Q33884068-F099AEB4-FA4D-45F9-A1C1-5E766AE1B355

P356

Q33884068-0CEC0B01-C081-4FE0-A15C-36098077D835

P433

Q33884068-3531E974-A8D0-4638-9AF9-D7D0ACFB9A9E

P478

Q33884068-0069CD99-3DC9-4DF1-BDC2-DFE7EDA3AF27

P50

Q33884068-5ED97525-DB48-4B55-A112-1E0E62D5AD7E

P577

Q33884068-711BBC97-6044-418A-AA3B-ED306BE72511

P5875

Q33884068-28411462-BA7D-4F9D-AA0D-8BF92B029345

P698

Q33884068-0DC7FCC8-BF4B-4B0A-8B7F-71B7D87133D3

P921

Q33884068-98C0BFFA-2F5A-4E42-941E-39D597BD0276

Q33884068-E1CE697C-AE79-422C-91B0-A40865E67E38

Q33884068-F99F838E-86DB-40A3-B541-F2FA1C7DB0E6

P932

Q33884068-C04DEF44-4950-4AFA-9901-EB711090A0B8

P356

P1433

Emerging Infectious Diseases

P1476

Antiretroviral therapy during ...... V-infected patients, Thailand.

@en

P2093

Charles D Wells

http://www.w3.org/2001/XMLSchema#string

Daranee Viriyakitja

http://www.w3.org/2001/XMLSchema#string

Dhanida Rienthong

http://www.w3.org/2001/XMLSchema#string

Jay K Varma

http://www.w3.org/2001/XMLSchema#string

Opart Karnkawinpong

http://www.w3.org/2001/XMLSchema#string

Patama Monkongdee

http://www.w3.org/2001/XMLSchema#string

Somsak Akksilp

http://www.w3.org/2001/XMLSchema#string

Taweesap Siraprapasiri

http://www.w3.org/2001/XMLSchema#string

Walya Sitti

http://www.w3.org/2001/XMLSchema#string

Wanpen Wattanaamornkiat

http://www.w3.org/2001/XMLSchema#string

P2860

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

The Côte d'Ivoire national HIV counseling and testing program for tuberculosis patients: implementation and analysis of epidemiologic data.

Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy.

Decline in the AIDS and death rates in the EuroSIDA study: an observational study.

Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Côte d'Ivoire.

Virological response to highly active antiretroviral therapy is unaffected by antituberculosis therapy.

The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia.

Cohort study of human immunodeficiency virus infection in patients with tuberculosis in Nairobi, Kenya. Analysis of early (6-month) mortality.

Acquired rifamycin resistance with twice-weekly treatment of HIV-related tuberculosis.

Clinical presentation of hospitalized adult patients with HIV infection and AIDS in Bangkok, Thailand.

P304

1001-1007

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3201/EID1307.061506

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Jordan W Tappero

P577

2007-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5637913

http://www.w3.org/2001/XMLSchema#string

P698

18214171

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

antiretroviral drug

P932

2878231

http://www.w3.org/2001/XMLSchema#string